Laura Lebrón-Mora
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Laura Lebrón-Mora has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Gabriela Pavlinkova
Laboratory of Molecular Pathogenetics, Institute of Biotechnology Czech Academy of Sciences
3 shared publications - Romana Bohuslavova
Laboratory of Molecular Pathogenetics, Institute of Biotechnology CAS, Vestec, Czechia
3 shared publications - Pavel Abaffy
Laboratory of Glial Biology and Omics Technologies Institute of Biotechnology of the Czech Academy of Sciences Vestec Czech Republic
2 shared publications - Zuzana Berkova
Institute for Clinical and Experimental Medicine, Prague, Czech Republic
2 shared publications Bernd Fritzsch
Department of Neurological Sciences, University of Nebraska Medical Center
1 shared publication- Bernd Fritzsch
Department of Neurological Sciences, University of Nebraska Medical Center, Omaha, NE 68198, USA
1 shared publication
Latest Publications
- Open Access
- 13 November 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (47)
Two-phase NEUROD1 pioneer activity synchronizes sensory neuronal differentiation and subtype specification
Temporal control of neuronal differentiation is essential for establishing stable neuronal identities, yet the transcriptional and epigenetic mechanisms underlying this process remain poorly understood. Using auditory neurons as an in vivo model, we investigate the role of the proneural factor NEUROD1 in regulating neuronal differentiation timing and subtype specification. To bypass early neuronal loss in germline Neurod1 deletion mutants, we generated a delayed, self-terminating conditional knockout mouse ( Neurod1ST ) that permits analysis of later differentiation stages. Integration of NEUROD1 chromatin binding and histone profiling at embryonic day (E) 11.5 with transcriptomic analyses across E11.5, E14.5, and E18.5 reveals a two-phase regulatory program during auditory neuron development that parallels dynamic Neurod1 expression. In the first phase, coinciding with Neurod1 upregulation during early neuronal differentiation, NEUROD1 preferentially binds putative enhancers of neuronal differentiation genes and promotes their transition to active chromatin states, consistent with pioneer factor activity. Loss of Neurod1 disrupts these epigenomic transitions, resulting in persistence of progenitor-like states with premature activation of differentiation and axonogenesis programs. This dysregulation is accompanied by activation of alternative regulatory networks, leading to defective neuronal migration and innervation, progressive identity instability, and apoptosis. In the second phase, marked by reexpression of Neurod1 in developing Type Ib/Ic precursors, Neurod1 deletion selectively impairs Type Ic specification while promoting a Type Ib-like identity. These findings identify NEUROD1 as a temporal regulator that coordinates developmental progression and stabilizes auditory neuron identity through phased regulatory activity, providing a mechanistic framework for how pioneer transcription factors couple chromatin remodeling to developmental timing.
- 13 November 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (47)
Open AccessTwo-phase NEUROD1 pioneer activity synchronizes sensory neuronal differentiation and subtype specification
Temporal control of neuronal differentiation is essential for establishing stable neuronal identities, yet the transcriptional and epigenetic mechanisms underlying this process remain poorly understood. Using auditory neurons as an in vivo model, we investigate the role of the proneural factor NEUROD1 in regulating neuronal differentiation timing and subtype specification. To bypass early neuronal loss in germline Neurod1 deletion mutants, we generated a delayed, self-terminating conditional knockout mouse ( Neurod1ST ) that permits analysis of later differentiation stages. Integration of NEUROD1 chromatin binding and histone profiling at embryonic day (E) 11.5 with transcriptomic analyses across E11.5, E14.5, and E18.5 reveals a two-phase regulatory program during auditory neuron development that parallels dynamic Neurod1 expression. In the first phase, coinciding with Neurod1 upregulation during early neuronal differentiation, NEUROD1 preferentially binds putative enhancers of neuronal differentiation genes and promotes their transition to active chromatin states, consistent with pioneer factor activity. Loss of Neurod1 disrupts these epigenomic transitions, resulting in persistence of progenitor-like states with premature activation of differentiation and axonogenesis programs. This dysregulation is accompanied by activation of alternative regulatory networks, leading to defective neuronal migration and innervation, progressive identity instability, and apoptosis. In the second phase, marked by reexpression of Neurod1 in developing Type Ib/Ic precursors, Neurod1 deletion selectively impairs Type Ic specification while promoting a Type Ib-like identity. These findings identify NEUROD1 as a temporal regulator that coordinates developmental progression and stabilizes auditory neuron identity through phased regulatory activity, providing a mechanistic framework for how pioneer transcription factors couple chromatin remodeling to developmental timing.
- 17 February 2026
- Published by American Diabetes Association in Diabetes
- Vol. 75 (4) , 646-660
ISL1 Restricts Progenitor Programs and Promotes β-Cell Maturation, Revealing Sex Differences in Diabetes Progression
Pancreatic islet cells differentiate from a common progenitor pool through tightly regulated transcriptional and epigenetic programs. ISL1, a LIM homeodomain transcription factor, is essential for islet development, but its molecular functions remain poorly defined. Here, we demonstrate that ISL1 is critical for maintaining endocrine cell identity and enabling terminal differentiation, particularly of α- and β-cells. Using conditional Isl1 deletion in endocrine precursors, combined with single-cell RNA sequencing and chromatin profiling (H3K27ac and H3K27me3), we reveal disruption of the transcriptional and epigenetic landscape in Isl1-deficient islets. Loss of Isl1 results in the failure to establish α-cell identity, loss of δ- and γ-cell lineages, and the persistence of immature β-cells with impaired functional profiles in Isl1CKO mice. Longitudinal single-cell analysis shows that Isl1CKO endocrine cells exhibit sustained progenitor-like states and defective β-cell maturation. These defects are accompanied by activation of stress and diabetes-associated transcriptional programs, along with sex-specific responses that may influence disease onset and progression. Mechanistically, ISL1 represses intermediate progenitor programs and facilitates chromatin remodeling necessary for endocrine lineage commitment and terminal maturation. Our findings highlight a previously underappreciated role for ISL1 in preserving endocrine cell fate and function and offer insight into how its dysregulation may contribute to diabetes. Article Highlights: ISL1 is a known maturity-onset diabetes of the young candidate and type 2 diabetes susceptibility gene, yet its molecular role in pancreatic endocrine maturation has remained unresolved. Deletion of Isl1 in endocrine progenitors results in islets composed of dysfunctional α-cells lacking glucagon production and immature β-cells with impaired basal insulin secretion, ultimately accelerating diabetes progression. ISL1 functions as a transcriptional repressor guiding chromatin remodeling and transcriptional transitions toward hormone-producing endocrine cells. The metabolic phenotype resulting from Isl1 deletion is associated with sustained progenitor-like states and activation of diabetes- and stress-associated pathways, with distinct sex-specific responses observed between male and female mice.
- 17 February 2026
- Published by American Diabetes Association in Diabetes
- Vol. 75 (4) , 646-660
ISL1 Restricts Progenitor Programs and Promotes β-Cell Maturation, Revealing Sex Differences in Diabetes Progression
Pancreatic islet cells differentiate from a common progenitor pool through tightly regulated transcriptional and epigenetic programs. ISL1, a LIM homeodomain transcription factor, is essential for islet development, but its molecular functions remain poorly defined. Here, we demonstrate that ISL1 is critical for maintaining endocrine cell identity and enabling terminal differentiation, particularly of α- and β-cells. Using conditional Isl1 deletion in endocrine precursors, combined with single-cell RNA sequencing and chromatin profiling (H3K27ac and H3K27me3), we reveal disruption of the transcriptional and epigenetic landscape in Isl1-deficient islets. Loss of Isl1 results in the failure to establish α-cell identity, loss of δ- and γ-cell lineages, and the persistence of immature β-cells with impaired functional profiles in Isl1CKO mice. Longitudinal single-cell analysis shows that Isl1CKO endocrine cells exhibit sustained progenitor-like states and defective β-cell maturation. These defects are accompanied by activation of stress and diabetes-associated transcriptional programs, along with sex-specific responses that may influence disease onset and progression. Mechanistically, ISL1 represses intermediate progenitor programs and facilitates chromatin remodeling necessary for endocrine lineage commitment and terminal maturation. Our findings highlight a previously underappreciated role for ISL1 in preserving endocrine cell fate and function and offer insight into how its dysregulation may contribute to diabetes. Article Highlights: ISL1 is a known maturity-onset diabetes of the young candidate and type 2 diabetes susceptibility gene, yet its molecular role in pancreatic endocrine maturation has remained unresolved. Deletion of Isl1 in endocrine progenitors results in islets composed of dysfunctional α-cells lacking glucagon production and immature β-cells with impaired basal insulin secretion, ultimately accelerating diabetes progression. ISL1 functions as a transcriptional repressor guiding chromatin remodeling and transcriptional transitions toward hormone-producing endocrine cells. The metabolic phenotype resulting from Isl1 deletion is associated with sustained progenitor-like states and activation of diabetes- and stress-associated pathways, with distinct sex-specific responses observed between male and female mice.
- Open Access
- 10 December 2024
- Published by Wiley in Journal of Comparative Neurology
- Vol. 532 (12) , e70008
Irx3/5 Null Deletion in Mice Blocks Cochlea‐Saccule Segregation and Disrupts the Auditory Tonotopic Map
A gene cadre orchestrates the normal development of sensory and non‐sensory cells in the inner ear, segregating the cochlea with a distinct tonotopic sound frequency map, similar brain projection, and five vestibular end‐organs. However, the role of genes driving the ear development is largely unknown. Here, we show double deletion of the Iroquois homeobox 3 and 5 transcription factors (Irx3/5 DKO) leads to the fusion of the saccule and the cochlear base. The overlying otoconia and tectorial membranes are absent in the Irx3/5 DKO inner ear, and the primary auditory neurons project fibers to both the saccule and cochlear hair cells. The central neuronal projections from the cochlear apex‐base contour are not fully segregated into a dorsal and ventral innervation in the Irx3/5 DKO cochlear nucleus, obliterating the characteristic tonotopic auditory map. Additionally, Irx3/5 deletion reveals a pronounced cochlear‐apex‐vestibular “vestibular‐cochlear” nerve (VCN) bilateral connection that is less noticeable in wild‐type control mice. Moreover, the incomplete segregation of apex and base projections that expands fibers to connect with vestibular nuclei. The results suggest the mammalian cochlear apex is a derived lagena reminiscent of sarcopterygians. Thus, Irx3 and 5 are potential evolutionary branch‐point genes necessary for balance‐sound segregation, which fused into a saccule‐cochlea organization.
- 10 December 2024
- Published by Wiley in Journal of Comparative Neurology
- Vol. 532 (12) , e70008
Open AccessIrx3/5 Null Deletion in Mice Blocks Cochlea‐Saccule Segregation and Disrupts the Auditory Tonotopic Map
A gene cadre orchestrates the normal development of sensory and non‐sensory cells in the inner ear, segregating the cochlea with a distinct tonotopic sound frequency map, similar brain projection, and five vestibular end‐organs. However, the role of genes driving the ear development is largely unknown. Here, we show double deletion of the Iroquois homeobox 3 and 5 transcription factors (Irx3/5 DKO) leads to the fusion of the saccule and the cochlear base. The overlying otoconia and tectorial membranes are absent in the Irx3/5 DKO inner ear, and the primary auditory neurons project fibers to both the saccule and cochlear hair cells. The central neuronal projections from the cochlear apex‐base contour are not fully segregated into a dorsal and ventral innervation in the Irx3/5 DKO cochlear nucleus, obliterating the characteristic tonotopic auditory map. Additionally, Irx3/5 deletion reveals a pronounced cochlear‐apex‐vestibular “vestibular‐cochlear” nerve (VCN) bilateral connection that is less noticeable in wild‐type control mice. Moreover, the incomplete segregation of apex and base projections that expands fibers to connect with vestibular nuclei. The results suggest the mammalian cochlear apex is a derived lagena reminiscent of sarcopterygians. Thus, Irx3 and 5 are potential evolutionary branch‐point genes necessary for balance‐sound segregation, which fused into a saccule‐cochlea organization.
- Open Access
- 9 September 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-20
NEUROD1 reinforces endocrine cell fate acquisition in pancreatic development
NEUROD1 is a transcription factor that helps maintain a mature phenotype of pancreatic β cells. Disruption ofNeurod1during pancreatic development causes severe neonatal diabetes; however, the exact role of NEUROD1 in the differentiation programs of endocrine cells is unknown. Here, we report a crucial role of the NEUROD1 regulatory network in endocrine lineage commitment and differentiation. Mechanistically, transcriptome and chromatin landscape analyses demonstrate thatNeurod1inactivation triggers a downregulation of endocrine differentiation transcription factors and upregulation of non-endocrine genes within theNeurod1-deficient endocrine cell population, disturbing endocrine identity acquisition.Neurod1deficiency altered the H3K27me3 histone modification pattern in promoter regions of differentially expressed genes, which resulted in gene regulatory network changes in the differentiation pathway of endocrine cells, compromising endocrine cell potential, differentiation, and functional properties.
- 9 September 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-20
Open AccessNEUROD1 reinforces endocrine cell fate acquisition in pancreatic development
NEUROD1 is a transcription factor that helps maintain a mature phenotype of pancreatic β cells. Disruption ofNeurod1during pancreatic development causes severe neonatal diabetes; however, the exact role of NEUROD1 in the differentiation programs of endocrine cells is unknown. Here, we report a crucial role of the NEUROD1 regulatory network in endocrine lineage commitment and differentiation. Mechanistically, transcriptome and chromatin landscape analyses demonstrate thatNeurod1inactivation triggers a downregulation of endocrine differentiation transcription factors and upregulation of non-endocrine genes within theNeurod1-deficient endocrine cell population, disturbing endocrine identity acquisition.Neurod1deficiency altered the H3K27me3 histone modification pattern in promoter regions of differentially expressed genes, which resulted in gene regulatory network changes in the differentiation pathway of endocrine cells, compromising endocrine cell potential, differentiation, and functional properties.